Osaic Holdings’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-30,300
Closed -$2K 7714
2022
Q4
$2K Buy
30,300
+14,755
+95% +$1.87K ﹤0.01% 6768
2022
Q3
$2K Buy
15,545
+14,980
+2,651% +$3.15K ﹤0.01% 6907
2022
Q2
$0 Buy
+565
New +$146 ﹤0.01% 7770
2022
Q1
Sell
-365
Closed -$1K 7730
2021
Q4
$1K Buy
365
+75
+26% +$221 ﹤0.01% 7317
2021
Q3
$1K Hold
290
﹤0.01% 7131
2021
Q2
$1K Hold
290
﹤0.01% 6935
2021
Q1
$1K Hold
290
﹤0.01% 6738
2020
Q4
$1K Hold
290
﹤0.01% 6327
2020
Q3
$0 Hold
290
﹤0.01% 6511
2020
Q2
$1K Hold
290
﹤0.01% 6035
2020
Q1
$0 Buy
+290
New +$592 ﹤0.01% 6254

Other funds holding STAB

Osaic Holdings's STAB Position: Q1 2023 in Review

Osaic Holdings sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q1 2023, closing a stake of 30,300 shares — an estimated $2K sold.

Osaic Holdings first reported a position in STAB in Q1 2020 and held it in 11 quarters. The position peaked at $2K in Q4 2022. 4 funds tracked by Wall St. Rank hold STAB as of Q1 2023.

  • Osaic Holdings reported no remaining Statera Biopharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Osaic Holdings sold 30,300 Statera Biopharma, Inc. Common Stock shares in Q1 2023, an estimated $2K.
  • Osaic Holdings first reported a position in Statera Biopharma, Inc. Common Stock in Q1 2020 and held it in 11 quarters.
  • Osaic Holdings's Statera Biopharma, Inc. Common Stock position peaked at $2K in Q4 2022.
  • 4 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q1 2023.

Based on Osaic Holdings's 13F filing for Q1 2023, filed 12 May 2023.